Related Experiment Videos
[Neonatal screening for congenital hypothyroidism]
D Möslinger1, H Frisch, W Strobl
1Osterreichischen Früherfassungsprogramm für Angeborene Stoffwechselerkrankungen, Universitätsklinik für Kinder- und Jugendheilkunde, Wien.
Acta Medica Austriaca
|January 1, 1997
Summary
Austria
Area of Science:
- Pediatrics
- Endocrinology
- Public Health
Context:
- Neonatal screening for congenital hypothyroidism (CH) in Austria since 1976.
- Part of the national screening program for inborn errors of metabolism.
- Utilizes capillary blood spots analyzed via delayed fluorescence-immunoassay (DELFIA) for thyroid-stimulating hormone (TSH).
Purpose:
- To report on the effectiveness and outcomes of Austria's neonatal screening program for congenital hypothyroidism.
- To analyze screening data and identify trends in CH detection.
Summary:
- Detected 105 cases of CH among 365,120 newborns screened since 1992.
- Achieved a recall rate of approximately 0.35% for the primary TSH screening.
- The screening identifies primary CH but not secondary or tertiary forms.
Impact:
- Early detection of primary congenital hypothyroidism enables timely treatment, preventing developmental issues.
- The study highlights potential challenges to screening accuracy due to early hospital discharges and physiological TSH levels in newborns.
- Suggests a need for program evaluation and potential adjustments to maintain screening efficacy.